|
Status |
Public on Oct 28, 2006 |
Title |
ABI_A2780_6h_rep1 |
Sample type |
RNA |
|
|
Source name |
A2780 ovarian carcinoma cell line
|
Organism |
Homo sapiens |
Characteristics |
A2780 ovarian carcinoma cell line
|
Biomaterial provider |
ECACC (Cat no.93112519)
|
Treatment protocol |
Human Ovarian cell line A2780 was untreated or exposed to 3 micromolar of a cell cycle inhibitor for 6hrs
|
Growth protocol |
A2780 was grown in RMPI 1640 + 10% FCS +2mM Glutamine and maintained at 37C in an atmosphere of 5% CO2 and 95% room air. Cells were plated at 2 x 106 cell/ml and after 24hrs were exposed to 3 micromolar of the inhibitor for 6hrs.
|
Extracted molecule |
total RNA |
Extraction protocol |
Total RNA extraction was performed using Qiagen RNeasy Mini kit 74106 following manufacturers instructions.
|
Label |
Digoxigenin-UTP
|
Label protocol |
2 micrograms of each RNA sample was labeled with Digoxigenin-UTP using the ABI Chemiluminescent RT-IVT Labeling Kit v 1.0 accordingly to manufacturer’s protocol.
|
|
|
Hybridization protocol |
10micrograms of the labeled cRNA was hybridized to ABI Human Genome Survey Microarray v 1.0 accordingly to ABI’s protocol.
|
Scan protocol |
Following hybridization and washing steps, chemiluminescent detection and image acquisition was performed using Applied Biosystems 1700 Chemiluminescent Microarrays Analyzer, following manufacturer’s protocol.
|
Description |
Human Ovarian cell line A2780 was obtained from ECACC (Cat no.93112519) and cells were untreated or exposed to 3 micromolar of a cell cycle inhibitor for 6hrs. Three biological replicates were performed for each treatment. Only attached cells were harvested. RNA was purified using a Qiagen RNA purification kit. RNA was quantitated using a spectrophotometer and the quality of the RNA was assessed using a Bioanalyser. Biological replicates were pooled to obtain a unique sample for each treatment, which was then divided to generate three aliquots for each condition (technical replicates).
|
Data processing |
Global median normalization was applied
|
|
|
Submission date |
Oct 26, 2006 |
Last update date |
Oct 27, 2006 |
Contact name |
Roberta Bosotti |
E-mail(s) |
roberta.bosotti@nervianoms.com
|
Organization name |
Nerviano Medical Sciences srl
|
Department |
Biotechnology
|
Lab |
Genomics
|
Street address |
viale Pasteur,10
|
City |
Nerviano |
State/province |
MI |
ZIP/Postal code |
20014 |
Country |
Italy |
|
|
Platform ID |
GPL1426 |
Series (1) |
GSE6140 |
Cross platform microarray analysis for robust identification of differentially expressed genes |
|